A rapid and systematic review of the clinical effectiveness and cost-effectiveness of gemcitabine for the treatment of pancreatic cancer | Synapse

⌘+K

Keep reading

Synapse has enriched 5 related papers. Consider them for comparative context:

1Treatments for metastatic non-small cell lung cancer: a pathways pilot with systematic review, evidence synthesis and economic modelHealth Technology Assessment · 2025
2Outpatient paracentesis for Ovarian Hyperstimulation Syndrome: STOP-OHSS feasibility study and RCT SynopsisHealth Technology Assessment · 2025
3Effectiveness of intensive community care services for adolescents with acute psychiatric emergencies: findings from a feasibility multi-centre, parallel-group, single-blinded RCTHealth Technology Assessment · 2025
4Effects and costs of a group-based educational intervention to reduce opioid use in people with chronic pain: I-WOTCH RCTHealth Technology Assessment · 2025
5Fenofibrate and progression of retinopathy in adults with diabetes: the randomised placebo-controlled LENS trialHealth Technology Assessment · 2025

More from Health Technology Assessment

More from University of Sheffield